| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.723 | 0.004 | 0.905 | Non-steroidal antiinflammatory agent | 0.905 0.002 DBMET00652 | DBMET00652 | |
| 0.577 | 0.06 | 0.802 | Antiinflammatory | 0.802 0.015 DBMET00652 | DBMET00652 | |
| 0.539 | 0.024 | 0.74 | Antithrombotic | 0.74 0.006 DBMET00652 | DBMET00652 | |
| 0.547 | 0.038 | 0.715 | Cyclophilin D inhibitor | 0.715 0.013 DBMET00652 | DBMET00652 | |
| 0.493 | 0.051 | 0.493 | Analgesic | 0.236 0.196 DBMET00652 | ||
| 0.426 | 0.004 | 0.426 | Interleukin 8 antagonist | 0.112 0.073 DBMET00652 | ||
| 0.418 | 0.025 | 0.586 | Hypoglycemic | 0.586 0.009 DBMET00652 | DBMET00652 | |
| 0.424 | 0.066 | 0.424 | Calcium channel L-type activator | 0.235 0.222 DBMET00652 | ||
| 0.352 | 0.011 | 0.352 | Cyclooxygenase inhibitor | 0.264 0.023 DBMET00652 | ||
| 0.35 | 0.01 | 0.35 | Cyclooxygenase 1 inhibitor | 0.242 0.023 DBMET00652 | ||
| 0.366 | 0.029 | 0.366 | Insulysin inhibitor | |||
| 0.324 | 0.004 | 0.324 | Aldose reductase inhibitor | 0.186 0.008 DBMET00652 | ||
| 0.356 | 0.043 | 0.474 | Interleukin 2 agonist | 0.474 0.011 DBMET00652 | DBMET00652 | |
| 0.369 | 0.057 | 0.609 | Cholesterol antagonist | 0.609 0.018 DBMET00652 | DBMET00652 | |
| 0.358 | 0.054 | 0.358 | Aldehyde oxidase inhibitor | |||
| 0.309 | 0.007 | 0.309 | Ferrochelatase inhibitor | |||
| 0.317 | 0.036 | 0.317 | Anticonvulsant | |||
| 0.318 | 0.047 | 0.352 | Platelet antagonist | 0.352 0.038 DBMET00652 | DBMET00652 | |
| 0.3 | 0.033 | 0.3 | Gastrin inhibitor | |||
| 0.297 | 0.034 | 0.297 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.311 | 0.052 | 0.311 | Cardiotonic | 0.179 0.14 DBMET00652 | ||
| 0.272 | 0.017 | 0.272 | Cyclooxygenase 2 inhibitor | 0.191 0.033 DBMET00652 | ||
| 0.319 | 0.073 | 0.319 | Calcium channel activator | |||
| 0.312 | 0.069 | 0.312 | Sodium/bile acid cotransporter inhibitor | |||
| 0.252 | 0.013 | 0.252 | GABA C receptor agonist | |||
| 0.274 | 0.054 | 0.274 | Interleukin antagonist | |||
| 0.223 | 0.015 | 0.223 | Arachidonic acid antagonist | 0.136 0.106 DBMET00652 | ||
| 0.207 | 0.005 | 0.207 | 5-Alpha-reductase inhibitor | 0.044 0.022 DBMET00652 | ||
| 0.263 | 0.069 | 0.263 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.196 | 0.007 | 0.196 | Peroxisome proliferator-activated receptor gamma agonist | 0.079 0.042 DBMET00652 | ||
| 0.288 | 0.103 | 0.288 | Vasodilator, peripheral | 0.24 0.135 DBMET00652 | ||
| 0.231 | 0.047 | 0.231 | Insulin sensitizer | |||
| 0.186 | 0.008 | 0.186 | Prostaglandin antagonist | |||
| 0.255 | 0.077 | 0.255 | Aryl hydrocarbon receptor agonist | |||
| 0.246 | 0.069 | 0.248 | Hypolipemic | 0.248 0.068 DBMET00652 | DBMET00652 | |
| 0.292 | 0.115 | 0.292 | Toll-Like receptor 7 agonist | |||
| 0.213 | 0.04 | 0.213 | Diuretic | 0.178 0.055 DBMET00652 | ||
| 0.184 | 0.014 | 0.184 | Alcohol dehydrogenase inhibitor | 0.1 0.052 DBMET00652 | ||
| 0.276 | 0.107 | 0.276 | Thyroid hormone antagonist | |||
| 0.286 | 0.12 | 0.286 | Toll-Like receptor agonist | |||
| 0.256 | 0.096 | 0.256 | Lipoxygenase inhibitor | |||
| 0.183 | 0.029 | 0.183 | Cystathionine beta-synthase inhibitor | 0.095 0.083 DBMET00652 | ||
| 0.221 | 0.073 | 0.221 | RNA-directed DNA polymerase inhibitor | 0.193 0.11 DBMET00652 | ||
| 0.182 | 0.04 | 0.224 | Alpha-N-acetylglucosaminidase inhibitor | 0.224 0.028 DBMET00652 | DBMET00652 | |
| 0.156 | 0.019 | 0.156 | Porphobilinogen synthase inhibitor | |||
| 0.25 | 0.118 | 0.25 | Thyroid hormone beta antagonist | |||
| 0.133 | 0.005 | 0.133 | Bradykinin antagonist | |||
| 0.155 | 0.032 | 0.164 | Ca2+-transporting ATPase inhibitor | 0.164 0.019 DBMET00652 | DBMET00652 | |
| 0.148 | 0.027 | 0.148 | Adenylate kinase inhibitor | |||
| 0.123 | 0.003 | 0.123 | Bradykinin B2 receptor antagonist | 0.048 0.009 DBMET00652 | ||
| 0.124 | 0.004 | 0.124 | Prostaglandin D2 antagonist | |||
| 0.217 | 0.1 | 0.217 | Superoxide dismutase inhibitor | |||
| 0.219 | 0.103 | 0.291 | Interleukin agonist | 0.291 0.053 DBMET00652 | DBMET00652 | |
| 0.29 | 0.177 | 0.29 | 5 Hydroxytryptamine release inhibitor | 0.246 0.233 DBMET00652 | ||
| 0.195 | 0.084 | 0.195 | Pyruvate kinase inhibitor | |||
| 0.255 | 0.144 | 0.51 | Immunosuppressant | 0.51 0.03 DBMET00652 | DBMET00652 | |
| 0.137 | 0.029 | 0.138 | Uric acid excretion stimulant | 0.138 0.028 DBMET00652 | DBMET00652 | |
| 0.136 | 0.03 | 0.136 | DOPA decarboxylase inhibitor | |||
| 0.255 | 0.151 | 0.291 | Histamine release inhibitor | 0.291 0.129 DBMET00652 | DBMET00652 | |
| 0.135 | 0.031 | 0.135 | Creatine kinase inhibitor | |||
| 0.176 | 0.074 | 0.176 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET00652 | ||
| 0.163 | 0.064 | 0.163 | Phospholipase A2 inhibitor | 0.122 0.114 DBMET00652 | ||
| 0.257 | 0.159 | 0.257 | 15-Lipoxygenase inhibitor | |||
| 0.131 | 0.033 | 0.131 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.173 | 0.077 | 0.173 | Succinate dehydrogenase inhibitor | |||
| 0.25 | 0.154 | 0.25 | GABA C receptor rho-3 antagonist | |||
| 0.105 | 0.011 | 0.105 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.238 | 0.146 | 0.399 | Vasodilator, coronary | 0.399 0.036 DBMET00652 | DBMET00652 | |
| 0.112 | 0.02 | 0.112 | Leukotriene synthesis inhibitor | |||
| 0.115 | 0.025 | 0.115 | Glutamate release inhibitor | 0.114 0.027 DBMET00652 | ||
| 0.092 | 0.005 | 0.092 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.113 | 0.028 | 0.113 | Bile acid receptor antagonist | |||
| 0.13 | 0.046 | 0.145 | Photosensitizer | 0.145 0.034 DBMET00652 | DBMET00652 | |
| 0.185 | 0.102 | 0.6 | Angiogenesis stimulant | 0.6 0.007 DBMET00652 | DBMET00652 | |
| 0.117 | 0.034 | 0.155 | Triose-phosphate isomerase inhibitor | 0.155 0.019 DBMET00652 | DBMET00652 | |
| 0.174 | 0.091 | 0.174 | Anesthetic general | 0.14 0.125 DBMET00652 | ||
| 0.109 | 0.027 | 0.109 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.095 | 0.014 | 0.095 | Glutamate (mGluR7) antagonist | |||
| 0.185 | 0.106 | 0.19 | Cyclic AMP phosphodiesterase inhibitor | 0.19 0.101 DBMET00652 | DBMET00652 | |
| 0.144 | 0.065 | 0.144 | Pregnane X receptor agonist | |||
| 0.095 | 0.018 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.084 | 0.01 | 0.084 | Thromboxane synthase inhibitor | |||
| 0.101 | 0.029 | 0.101 | Glutamate decarboxylase inhibitor | |||
| 0.129 | 0.058 | 0.129 | Cholesterol synthesis inhibitor | |||
| 0.083 | 0.019 | 0.083 | Thromboxane antagonist | |||
| 0.082 | 0.018 | 0.082 | MDM2 inhibitor | |||
| 0.097 | 0.033 | 0.097 | Histidine decarboxylase inhibitor | |||
| 0.111 | 0.049 | 0.111 | GABA C receptor rho-1 antagonist | |||
| 0.078 | 0.016 | 0.078 | Thromboxane A2 antagonist | |||
| 0.094 | 0.033 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.108 | 0.047 | 0.108 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.101 0.053 DBMET00652 | ||
| 0.17 | 0.11 | 0.17 | Neurotrophic factor enhancer | |||
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.081 | 0.024 | 0.081 | Maillard reaction inhibitor | |||
| 0.13 | 0.075 | 0.13 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.105 | 0.051 | 0.105 | Electrolyte absorption antagonist | |||
| 0.132 | 0.078 | 0.132 | Farnesoid X receptor antagonist | |||
| 0.105 | 0.051 | 0.105 | Potassium channel (Ca-activated) activator | |||
| 0.079 | 0.027 | 0.079 | Biliverdin reductase inhibitor | |||
| 0.058 | 0.007 | 0.058 | Retinoid X receptor antagonist | |||
| 0.115 | 0.067 | 0.206 | Microtubule formation inhibitor | 0.206 0.018 DBMET00652 | DBMET00652 | |
| 0.086 | 0.038 | 0.086 | HIV-1 reverse transcriptase inhibitor | |||
| 0.083 | 0.035 | 0.083 | Glycine receptor agonist | 0.071 0.053 DBMET00652 | ||
| 0.066 | 0.019 | 0.066 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.14 | 0.093 | 0.211 | Interferon gamma antagonist | 0.211 0.037 DBMET00652 | DBMET00652 | |
| 0.208 | 0.161 | 0.621 | Transcription factor NF kappa B inhibitor | 0.621 0.029 DBMET00652 | DBMET00652 | |
| 0.051 | 0.006 | 0.051 | Retinoid X alpha receptor antagonist | |||
| 0.122 | 0.078 | 0.122 | Tubulin antagonist | |||
| 0.209 | 0.165 | 0.209 | Thioredoxin glutathione reductase inhibitor | |||
| 0.065 | 0.022 | 0.065 | DNA helicase inhibitor | |||
| 0.108 | 0.066 | 0.108 | GABA C receptor antagonist | |||
| 0.064 | 0.022 | 0.064 | Aconitate hydratase inhibitor | |||
| 0.162 | 0.121 | 0.162 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.052 | 0.012 | 0.052 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.055 | 0.016 | 0.055 | Urate transporter 1 inhibitor | |||
| 0.052 | 0.014 | 0.052 | Retinoid X alpha receptor agonist | |||
| 0.062 | 0.024 | 0.062 | Leukotriene C antagonist | |||
| 0.106 | 0.069 | 0.106 | Chelator | |||
| 0.132 | 0.095 | 0.132 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.109 | 0.072 | 0.109 | Interleukin 1b antagonist | |||
| 0.047 | 0.01 | 0.047 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.083 | 0.047 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.021 DBMET00652 | DBMET00652 | |
| 0.09 | 0.056 | 0.09 | Ornithine decarboxylase inhibitor | |||
| 0.078 | 0.047 | 0.078 | Glutamate dehydrogenase inhibitor | |||
| 0.076 | 0.046 | 0.076 | Aminopeptidase I inhibitor | |||
| 0.091 | 0.061 | 0.091 | Protein kinase C delta inhibitor | |||
| 0.046 | 0.016 | 0.046 | p53 inhibitor | |||
| 0.154 | 0.124 | 0.154 | Platelet aggregation inhibitor | |||
| 0.133 | 0.105 | 0.133 | Heat shock protein 70 antagonist | |||
| 0.047 | 0.019 | 0.047 | Retinoid X receptor agonist | |||
| 0.068 | 0.042 | 0.068 | Leukotriene antagonist | |||
| 0.112 | 0.088 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.075 | 0.051 | 0.075 | Catalase inhibitor | |||
| 0.104 | 0.081 | 0.104 | Adenylate cyclase inhibitor | |||
| 0.099 | 0.079 | 0.099 | Mucolytic | 0.094 0.087 DBMET00652 | ||
| 0.041 | 0.021 | 0.041 | Leukotriene C4 antagonist | |||
| 0.033 | 0.013 | 0.033 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.025 | 0.007 | 0.025 | Retinoid X beta receptor antagonist | |||
| 0.074 | 0.057 | 0.074 | GABA B receptor agonist | |||
| 0.083 | 0.069 | 0.158 | NADH dehydrogenase inhibitor | 0.158 0.016 DBMET00652 | DBMET00652 | |
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | |||
| 0.042 | 0.029 | 0.042 | Angiotensin AT1 receptor antagonist | |||
| 0.018 | 0.005 | 0.018 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.11 | 0.098 | 0.119 | Antibacterial (Helicobacter pylori) | 0.119 0.083 DBMET00652 | DBMET00652 | |
| 0.198 | 0.186 | 0.198 | Beta lactamase inhibitor | |||
| 0.034 | 0.022 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.035 | 0.024 | 0.035 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.094 | 0.084 | 0.094 | GABA receptor agonist | |||
| 0.063 | 0.054 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.051 | 0.042 | 0.051 | Leukotriene B4 antagonist | |||
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | |||
| 0.128 | 0.12 | 0.128 | MAP kinase kinase 4 inhibitor | |||
| 0.173 | 0.164 | 0.264 | DNA synthesis inhibitor | 0.264 0.058 DBMET00652 | DBMET00652 | |
| 0.04 | 0.032 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.022 | 0.014 | 0.022 | Retinoid X beta receptor agonist | |||
| 0.045 | 0.038 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 DBMET00652 | DBMET00652 | |
| 0.026 | 0.019 | 0.026 | Thyroid hormone agonist | |||
| 0.084 | 0.078 | 0.084 | Aminopeptidase B inhibitor | |||
| 0.026 | 0.021 | 0.026 | Retinoid X gamma receptor antagonist | |||
| 0.017 | 0.011 | 0.017 | Vitamin D receptor agonist | 0.016 0.013 DBMET00652 | ||
| 0.019 | 0.014 | 0.019 | 5-Alpha-reductase 2 inhibitor | |||
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.039 | 0.034 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.008 | 0.003 | 0.008 | Insulin like growth factor 3 antagonist | |||
| 0.217 | 0.212 | 0.217 | DNA polymerase beta inhibitor | |||
| 0.062 | 0.059 | 0.062 | Glutamate (mGluR6) antagonist | |||
| 0.217 | 0.214 | 0.217 | DNA directed DNA polymerase inhibitor | |||
| 0.051 | 0.048 | 0.051 | Glutamate (mGluR1) antagonist | |||
| 0.064 | 0.062 | 0.064 | Cathepsin G inhibitor | |||
| 0.036 | 0.034 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.059 | 0.057 | 0.109 | Phosphofructokinase-1 inhibitor | 0.109 0.028 DBMET00652 | DBMET00652 | |
| 0.007 | 0.005 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.026 | 0.024 | 0.026 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.039 | 0.038 | 0.039 | Sphingosine 1-phosphate receptor agonist | |||
| 0.134 | 0.133 | 0.167 | ATPase inhibitor | 0.167 0.076 DBMET00652 | DBMET00652 | |
| 0.031 | 0.03 | 0.031 | Angiotensin II receptor antagonist | |||
| 0.048 | 0.05 | 0.083 | Heparanase inhibitor | 0.083 0.006 DBMET00652 | DBMET00652 | |
| 0.018 | 0.032 | 0.021 | Vitamin D receptor antagonist | 0.021 0.017 DBMET00652 | DBMET00652 | |
| 0.02 | 0.034 | 0.028 | Vanilloid 2 agonist | 0.028 0.013 DBMET00652 | DBMET00652 | |
| 0.245 | 0.26 | 0.336 | Caspase 9 stimulant | 0.336 0.157 DBMET00652 | DBMET00652 | |
| 0.079 | 0.098 | 0.186 | Expectorant | 0.186 0.023 DBMET00652 | DBMET00652 | |
| 0.1 | 0.121 | 0.119 | Protein kinase stimulant | 0.119 0.093 DBMET00652 | DBMET00652 | |
| 0.107 | 0.128 | 0.117 | Mannose-6-phosphate isomerase inhibitor | 0.117 0.107 DBMET00652 | DBMET00652 | |
| 0.047 | 0.072 | 0.087 | Adenine nucleotide translocase inhibitor | 0.087 0.006 DBMET00652 | DBMET00652 | |
| 0.085 | 0.114 | 0.238 | Amylase inhibitor | 0.238 0.032 DBMET00652 | DBMET00652 | |
| 0.087 | 0.126 | 0.18 | Cyclooxygenase 3 inhibitor | 0.18 0.028 DBMET00652 | DBMET00652 | |
| 0.07 | 0.112 | 0.217 | UDP-glucose 4-epimerase inhibitor | 0.217 0.016 DBMET00652 | DBMET00652 | |
| 0.085 | 0.128 | 0.102 | Acetylcholine release stimulant | 0.102 0.083 DBMET00652 | DBMET00652 | |
| 0.067 | 0.114 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.042 DBMET00652 | DBMET00652 | |
| 0.085 | 0.133 | 0.181 | Cell adhesion inhibitor | 0.181 0.03 DBMET00652 | DBMET00652 | |
| 0.062 | 0.118 | 0.091 | Mediator release inhibitor | 0.091 0.081 DBMET00652 | DBMET00652 | |
| 0.011 | 0.076 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET00652 | DBMET00652 | |
| 0.032 | 0.1 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET00652 | DBMET00652 | |
| 0.104 | 0.175 | 0.136 | Melanin inhibitor | 0.136 0.104 DBMET00652 | DBMET00652 | |
| 0.107 | 0.18 | 0.346 | Hepatoprotectant | 0.346 0.02 DBMET00652 | DBMET00652 | |
| 0.066 | 0.143 | 0.147 | DNA polymerase I inhibitor | 0.147 0.051 DBMET00652 | DBMET00652 | |
| 0.03 | 0.107 | 0.315 | Selectin antagonist | 0.315 0.005 DBMET00652 | DBMET00652 | |
| 0.141 | 0.223 | 0.336 | Peptidyltransferase inhibitor | 0.336 0.015 DBMET00652 | DBMET00652 | |
| 0.12 | 0.21 | 0.52 | Antioxidant | 0.52 0.018 DBMET00652 | DBMET00652 | |
| 0.109 | 0.203 | 0.435 | Immunostimulant | 0.435 0.04 DBMET00652 | DBMET00652 | |
| 0.02 | 0.116 | 0.048 | Mannosidase inhibitor | 0.048 0.028 DBMET00652 | DBMET00652 | |
| 0.067 | 0.169 | 0.095 | Phosphodiesterase 6D inhibitor | 0.095 0.062 DBMET00652 | DBMET00652 | |
| 0.061 | 0.172 | 0.135 | AMP-activated protein kinase stimulant | 0.135 0.038 DBMET00652 | DBMET00652 | |
| 0.049 | 0.161 | 0.097 | Cell adhesion molecule inhibitor | 0.097 0.037 DBMET00652 | DBMET00652 | |
| 0.04 | 0.159 | 0.156 | Monophenol monooxygenase inhibitor | 0.156 0.045 DBMET00652 | DBMET00652 | |
| 0.114 | 0.24 | 0.179 | DNA damaging | 0.179 0.135 DBMET00652 | DBMET00652 | |
| 0.021 | 0.147 | 0.096 | Protein 50S ribosomal subunit inhibitor | 0.096 0.014 DBMET00652 | DBMET00652 | |
| 0.083 | 0.22 | 0.16 | DNA repair enzyme inhibitor | 0.16 0.023 DBMET00652 | DBMET00652 | |
| 0.084 | 0.223 | 0.325 | Nitric oxide antagonist | 0.325 0.036 DBMET00652 | DBMET00652 | |
| 0.016 | 0.159 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET00652 | DBMET00652 | |
| 0.054 | 0.198 | 0.165 | Alkylator | 0.165 0.039 DBMET00652 | DBMET00652 | |
| 0.151 | 0.297 | 0.608 | Antibacterial | 0.608 0.018 DBMET00652 | DBMET00652 | |
| 0.055 | 0.203 | 0.152 | Multidrug resistance-associated protein 1 inhibitor | 0.152 0.024 DBMET00652 | DBMET00652 | |
| 0.077 | 0.229 | 0.157 | Hexokinase inhibitor | 0.157 0.071 DBMET00652 | DBMET00652 | |
| 0.065 | 0.221 | 0.114 | Interleukin 4 antagonist | 0.114 0.095 DBMET00652 | DBMET00652 | |
| 0.137 | 0.305 | 0.382 | Apoptosis antagonist | 0.382 0.044 DBMET00652 | DBMET00652 | |
| 0.037 | 0.213 | 0.058 | Lipocortins synthesis agonist | 0.058 0.039 DBMET00652 | DBMET00652 | |
| 0.006 | 0.19 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.015 DBMET00652 | DBMET00652 | |
| 0.018 | 0.205 | 0.045 | Microtubule stabilization | 0.045 0.035 DBMET00652 | DBMET00652 | |
| 0.016 | 0.205 | 0.145 | Antineoplastic antibiotic | 0.145 0.032 DBMET00652 | DBMET00652 | |
| 0.075 | 0.272 | 0.146 | P-glycoprotein inhibitor | 0.146 0.123 DBMET00652 | DBMET00652 | |
| 0.098 | 0.298 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.044 DBMET00652 | DBMET00652 | |
| 0.078 | 0.28 | 0.436 | Free radical scavenger | 0.436 0.024 DBMET00652 | DBMET00652 | |
| 0.045 | 0.253 | 0.253 | Lipid peroxidase inhibitor | 0.253 0.026 DBMET00652 | DBMET00652 | |
| 0.022 | 0.241 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.023 DBMET00652 | DBMET00652 | |
| 0.076 | 0.309 | 0.308 | Vasodilator | 0.308 0.045 DBMET00652 | DBMET00652 | |
| 0.054 | 0.302 | 0.158 | Cell wall synthesis inhibitor | 0.158 0.058 DBMET00652 | DBMET00652 | |
| 0.09 | 0.343 | 0.424 | Alpha-glucosidase inhibitor | 0.424 0.105 DBMET00652 | DBMET00652 | |
| 0.007 | 0.267 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET00652 | DBMET00652 | |
| 0.035 | 0.31 | 0.196 | Thrombolytic | 0.196 0.054 DBMET00652 | DBMET00652 | |
| 0.017 | 0.301 | 0.06 | Nitric oxide donor | 0.06 0.049 DBMET00652 | DBMET00652 | |
| 0.042 | 0.338 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 DBMET00652 | DBMET00652 | |
| 0.02 | 0.325 | 0.062 | Factor IXa inhibitor | 0.062 0.025 DBMET00652 | DBMET00652 | |
| 0.039 | 0.355 | 0.142 | Anticoagulant | 0.142 0.087 DBMET00652 | DBMET00652 | |
| 0.028 | 0.385 | 0.117 | Beta glucuronidase inhibitor | 0.117 0.049 DBMET00652 | DBMET00652 | |
| 0.042 | 0.427 | 0.287 | Platelet adhesion inhibitor | 0.287 0.038 DBMET00652 | DBMET00652 | |
| 0.096 | 0.484 | 0.55 | Apoptosis agonist | 0.55 0.06 DBMET00652 | DBMET00652 | |
| 0.032 | 0.43 | 0.162 | Toll-Like receptor 4 antagonist | 0.162 0.015 DBMET00652 | DBMET00652 | |
| 0.013 | 0.443 | 0.059 | Antibiotic Aminoglycoside-like | 0.059 0.009 DBMET00652 | DBMET00652 | |
| 0.014 | 0.481 | 0.142 | Topoisomerase I inhibitor | 0.142 0.044 DBMET00652 | DBMET00652 | |
| 0.058 | 0.537 | 0.328 | Immunomodulator | 0.328 0.068 DBMET00652 | DBMET00652 | |
| 0.043 | 0.525 | 0.163 | NOS3 expression enhancer | 0.163 0.061 DBMET00652 | DBMET00652 | |
| 0.005 | 0.576 | 0.027 | Protein 30S ribosomal subunit inhibitor | 0.027 0.014 DBMET00652 | DBMET00652 | |
| 0.009 | 0.8 | 0.272 | Tumour necrosis factor alpha release inhibitor | 0.272 0.065 DBMET00652 | DBMET00652 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |